Work

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.

Year: 1997

Type: article

Source: PubMed

Authors: P A Trail, D Willner, J Knipe, A J Henderson, S J Lasch, M E Zoeckler, M D TrailSmith, T W Doyle, H D King, A M Casazza, G R Braslawsky, J Brown, S J Hofstead, R S Greenfield, R A Firestone, K Mosure, K F Kadow, M B Yang, K E Hellström, I Hellström

Institutions: Bristol-Myers Squibb (United States), Wyeth, Vion Pharmaceuticals (United States), Biogen (United States)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1604721988

FWCI: 1.107

Cites:

Cited by: 56

Related to: 10